N-acetylcysteine prevents but does not reverse dexamethasone-induced hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 8, 2008, Pages 979-981

  Krug, Susanne ^a   Zhang, Yi ^a   Mori, Trevor A ^b   Croft, Kevin D ^b   Vickers, Janine J ^a   Langton, Leanne K ^a   Whitworth, Judith A ^a  

^a Australian National University   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dexamethasone; Hypertension; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; DEXAMETHASONE; ISOPROSTANE DERIVATIVE; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG MECHANISM; FLUID INTAKE; FOOD INTAKE; HYPERTENSION; MALE; METABOLISM; NONHUMAN; ORGAN WEIGHT; PROPHYLAXIS; RAT; SYSTOLIC BLOOD PRESSURE; THYMUS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ACETYLCYSTEINE; ANIMALS; BLOOD PRESSURE; DEXAMETHASONE; ENERGY METABOLISM; F2-ISOPROSTANES; HYPERTENSION; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 46749102164     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04947.x     Document Type: Article

References (21)

1. Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KUS, Whitworth JA. The anti-oxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 2004 17 : 260 5.
2. Hu L, Zhang Y, Lim PS et al. Apocynin but not l-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 2006 19 : 413 18.
3. Whitworth JA, Gordon D, Andrews J, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: Role of sodium and volume. J. Hypertens. 1989 7 : 537 49.
4. Wallerath T, Goedecke A, Molojavyi A, Li H, Schrader J, Foerstermann U. Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide 2004 10 : 36 41.
5. Wallerath T, Witte K, Schafer SC et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc. Natl Acad. Sci. USA 1999 96 : 13 357 62.
6. Radomski M, Palmer R, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. USA 1990 87 : 10 043 7.
7. Miao Y, Zhang Y, Lim PS et al. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat. Am. J. Hypertens. 2007 20 : 304 10.
8. Smilkstein MJ, Knapp GL, Kuig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analyses of a multicentre study (1976-85). N. Engl. J. Med. 1988 319 : 1557 62.
9. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N- Acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995 92 : 2855 62.
10. Mondo CK, Zhang Y, Possamai V et al. N-Acetylcysteine partially prevents but does not reverse ACTH-induced hypertension in the rat. Clin. Exp. Hypertens. 2006 28 : 73 84.
11. Turner SW, Wen C, Li M, Whitworth JA. l-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996 27 : 184 9.
12. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. l-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Pressure 2000 9 : 298 304.
13. Li M, Fraser T, Wang J, Whitworth JA. Dexamethasone-induced hypertension in the rat: Effects of l-arginine. Clin. Exp. Pharmacol. Physiol. 1997 24 : 730 2.
14. 2-isoprostanes using gas chromatography-mass spectrometry. Anal. Biochem. 1999 268 : 117 25.
15. Ong SLH, Vickers JJ, Zhang Y, McKenzie KUS, Walsh CE, Whitworth JA. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin. Exp. Pharmacol. Physiol. 2007 34 : 517 19.
16. Zhang Y, Miao Y, Whitworth JA. Aspirin prevents and reverses glucocorticoid-induced hypertension. Am. J. Hypertens. 2007 20 : 1222 8.
17. Corcoran GB, Wong BK. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-l-cysteine in vivo: Studies with N-acetyl-d-cysteine in mice. J. Pharmacol. Exp. Ther. 1986 238 : 54 61.
18. Ruffmann R, Wendel A. GSH rescue by N-acetylcysteine. Klin. Wochenschr. 1991 69 : 857 62.
19. Brunet J, Boily MJ, Cordeau S, Des Rosiers C. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: Evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic. Biol. Med. 1995 19 : 627 38.
20. Jeremias A, Dusa C, Forudi F et al. N-Acetyl-cysteine in the prevention of vascular restenosis after percutaneous balloon angioplasty. Int. J. Cardiol. 2004 95 : 255 60.
21. Pechánová O, Zicha J, Kojsová S, Dobesová Z, Jendeková L, Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin. Sci. 2006 110 : 235 42.